0.228
7.35%
-0.0181
시간 외 거래:
.23
0.002
+0.88%
Bionano Genomics Inc (BNGO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
18.21%
8.769
|
10.72 | 9.318 | 8.662 | 7.415 |
Cost Of Revenue |
28.23%
5.945
|
8.283 | 6.569 | 6.354 | 5.345 |
Gross Profit |
15.83%
2.824
|
2.438 | 2.749 | 2.308 | 2.07 |
Operating Expenses
|
23.93%
33.95
|
27.39 | 115.96 | 41.55 | 39.91 |
Interest Income/Expense |
97.51%
0.122
|
4.898 | 0.071 | 0.074 | 0.076 |
Benefits Costs and Expenses |
26.42%
40.21
|
54.65 | 121.84 | 47.54 | 44.51 |
Costs And Expenses |
23.93%
33.95
|
27.39 | 115.96 | 41.55 | 39.91 |
Operating Income/Loss |
24.73%
-31.12
|
-24.95 | -113.21 | -39.24 | -37.84 |
Nonoperating Income/Loss |
98.33%
-0.317
|
-18.97 | 0.685 | 0.359 | 0.745 |
Income/Loss From Continuing Operations Before Tax |
28.43%
-31.44
|
-43.93 | -112.53 | -38.88 | -37.10 |
Income Tax Expense/Benefit |
50.00%
-0.018
|
-0.036 | 0.039 | 0.033 | 0.026 |
Income/Loss From Continuing Operations After Tax |
28.41%
-31.42
|
-43.89 | -112.57 | -38.91 | -37.12 |
Net Income/Loss
|
28.41%
-31.42
|
-43.89 | -112.57 | -38.91 | -37.12 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,670%
52.74
|
1.904 | 35.00 | 31.50 | 302.05 |
Diluted Average Shares |
2,670%
52.74
|
1.904 | 35.00 | 31.50 | 302.05 |
Basic Earnings Per Share |
37.50%
-0.60
|
-0.96 | -3.22 | -1.24 | -0.12 |
Diluted Earnings Per Share |
37.50%
-0.60
|
-0.96 | -3.22 | -1.24 | -0.12 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):